Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Genetic Contributions to The Association Between Adult Height and Head and Neck Cancer: A Mendelian Randomization Analysis

R. Pastorino, A. Puggina, R. Carreras-Torres, P. Lagiou, I. Holcátová, L. Richiardi, K. Kjaerheim, A. Agudo, X. Castellsagué, TV. Macfarlane, L. Barzan, C. Canova, NS. Thakker, DI. Conway, A. Znaor, CM. Healy, W. Ahrens, D. Zaridze, N....

. 2018 ; 8 (1) : 4534. [pub] 20180314

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

With the aim to dissect the effect of adult height on head and neck cancer (HNC), we use the Mendelian randomization (MR) approach to test the association between genetic instruments for height and the risk of HNC. 599 single nucleotide polymorphisms (SNPs) were identified as genetic instruments for height, accounting for 16% of the phenotypic variation. Genetic data concerning HNC cases and controls were obtained from a genome-wide association study. Summary statistics for genetic association were used in complementary MR approaches: the weighted genetic risk score (GRS) and the inverse-variance weighted (IVW). MR-Egger regression was used for sensitivity analysis and pleiotropy evaluation. From the GRS analysis, one standard deviation (SD) higher height (6.9 cm; due to genetic predisposition across 599 SNPs) raised the risk for HNC (Odds ratio (OR), 1.14; 95% Confidence Interval (95%CI), 0.99-1.32). The association analyses with potential confounders revealed that the GRS was associated with tobacco smoking (OR = 0.80, 95% CI (0.69-0.93)). MR-Egger regression did not provide evidence of overall directional pleiotropy. Our study indicates that height is potentially associated with HNC risk. However, the reported risk could be underestimated since, at the genetic level, height emerged to be inversely associated with smoking.

Cancer Epidemiology Research Program Catalan Institute of Oncology Barcelona Spain

Cancer Epidemiology Research Program Catalan Institute of Oncology IDIBELL L'Hospitalet de Llobregat Catalonia Spain

Cancer Registry of Norway Oslo Norway

Croatian National Cancer Registry Croatian National Institute of Public Health Zagreb Croatia

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute and Masaryk University Brno Czech Republic

Department of Cancer Epidemiology and Prevention M Sklodowska Curie Memorial Cancer Center and Institute of Oncology Warsaw Poland

Department of Environmental Medicine and Public Health University of Padova Padova Italy MRC HPA Centre for Environment and Health Respiratory Epidemiology and Public Health National Heart and Lung Institute Imperial College London United Kingdom

Department of Epidemiology Institute of Occupational Medicine Lodz Poland

Department of Hygiene Epidemiology and Medical Statistics University of Athens School of Medicine Athens Greece

General Hospital of Pordenone Pordenone Italy

Institute of Carcinogenesis Cancer Research Centre Moscow Russian Federation

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

International Agency for Research on Cancer Lyon France

Leibniz Institute for Prevention Research and Epidemiology BIPS Bremen Germany Faculty of Mathematics and Computer Science University of Bremen Bremen Germany

Palacky University Olomouc Czech Republic

Regional Authority of Public Health Banska Bystrica Slovakia

Saint Mary General and Esophageal Surgery Clinic Carol Davila University of Medicine and Pharmacy Bucharest Romania

School of Medicine and Dentistry University of Aberdeen Aberdeen United Kingdom

Section of Hygiene Institute of Public Health Università Cattolica del Sacro Cuore IRCCS Fondazione Policlinico 'Agostino Gemelli' Rome Italy

Section of Hygiene Institute of Public Health Università Cattolica del Sacro Cuore L go F Vito 1 00168 Rome Italy

Trinity College School of Dental Science Dublin Ireland

University of Glasgow Dental School Glasgow Scotland United Kingdom

University of Manchester School of Dentistry Manchester United Kingdom

University of Turin Department of Medical Sciences Unit of Cancer Epidemiology Turin Italy

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035352
003      
CZ-PrNML
005      
20191008113029.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-018-22626-w $2 doi
035    __
$a (PubMed)29540730
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pastorino, Roberta $u Section of Hygiene - Institute of Public Health, Università Cattolica del Sacro Cuore, L.go F. Vito, 1, 00168, Rome, Italy.
245    10
$a Genetic Contributions to The Association Between Adult Height and Head and Neck Cancer: A Mendelian Randomization Analysis / $c R. Pastorino, A. Puggina, R. Carreras-Torres, P. Lagiou, I. Holcátová, L. Richiardi, K. Kjaerheim, A. Agudo, X. Castellsagué, TV. Macfarlane, L. Barzan, C. Canova, NS. Thakker, DI. Conway, A. Znaor, CM. Healy, W. Ahrens, D. Zaridze, N. Szeszenia-Dabrowska, J. Lissowska, E. Fabianova, IN. Mates, V. Bencko, L. Foretova, V. Janout, P. Brennan, V. Gaborieau, JD. McKay, S. Boccia,
520    9_
$a With the aim to dissect the effect of adult height on head and neck cancer (HNC), we use the Mendelian randomization (MR) approach to test the association between genetic instruments for height and the risk of HNC. 599 single nucleotide polymorphisms (SNPs) were identified as genetic instruments for height, accounting for 16% of the phenotypic variation. Genetic data concerning HNC cases and controls were obtained from a genome-wide association study. Summary statistics for genetic association were used in complementary MR approaches: the weighted genetic risk score (GRS) and the inverse-variance weighted (IVW). MR-Egger regression was used for sensitivity analysis and pleiotropy evaluation. From the GRS analysis, one standard deviation (SD) higher height (6.9 cm; due to genetic predisposition across 599 SNPs) raised the risk for HNC (Odds ratio (OR), 1.14; 95% Confidence Interval (95%CI), 0.99-1.32). The association analyses with potential confounders revealed that the GRS was associated with tobacco smoking (OR = 0.80, 95% CI (0.69-0.93)). MR-Egger regression did not provide evidence of overall directional pleiotropy. Our study indicates that height is potentially associated with HNC risk. However, the reported risk could be underestimated since, at the genetic level, height emerged to be inversely associated with smoking.
650    _2
$a senioři $7 D000368
650    _2
$a tělesná výška $x genetika $7 D001827
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a nádory hlavy a krku $x genetika $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mendelovská randomizace $x metody $7 D057182
650    _2
$a lidé středního věku $7 D008875
650    12
$a jednonukleotidový polymorfismus $7 D020641
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Puggina, Anna $u Section of Hygiene - Institute of Public Health, Università Cattolica del Sacro Cuore, L.go F. Vito, 1, 00168, Rome, Italy. annapuggina@gmail.com.
700    1_
$a Carreras-Torres, Robert $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Lagiou, Pagona $u Department of Hygiene, Epidemiology and Medical Statistics, University of Athens School of Medicine, Athens, Greece.
700    1_
$a Holcátová, Ivana $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Richiardi, Lorenzo $u University of Turin, Department of Medical Sciences, Unit of Cancer Epidemiology, Turin, Italy.
700    1_
$a Kjaerheim, Kristina $u Cancer Registry of Norway, Oslo, Norway.
700    1_
$a Agudo, Antonio $u Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain.
700    1_
$a Castellsagué, Xavier $u Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
700    1_
$a Macfarlane, Tatiana V $u School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom.
700    1_
$a Barzan, Luigi $u General Hospital of Pordenone, Pordenone, Italy.
700    1_
$a Canova, Cristina $u Department of Environmental Medicine and Public Health, University of Padova, Padova, Italy. MRC-HPA Centre for Environment and Health, Respiratory Epidemiology and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom.
700    1_
$a Thakker, Nalin S $u University of Manchester, School of Dentistry, Manchester, United Kingdom.
700    1_
$a Conway, David I $u University of Glasgow Dental School, Glasgow, Scotland, United Kingdom.
700    1_
$a Znaor, Ariana $u Croatian National Cancer Registry, Croatian National Institute of Public Health, Zagreb, Croatia.
700    1_
$a Healy, Claire M $u Trinity College School of Dental Science, Dublin, Ireland.
700    1_
$a Ahrens, Wolfgang $u Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany. Faculty of Mathematics and Computer Science, University of Bremen, Bremen, Germany.
700    1_
$a Zaridze, David $u Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russian Federation.
700    1_
$a Szeszenia-Dabrowska, Neonilia $u Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Lissowska, Jolanta $u Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
700    1_
$a Fabianova, Eleonora $u Regional Authority of Public Health, Banska Bystrica, Slovakia.
700    1_
$a Mates, Ioan Nicolae $u Saint Mary General and Esophageal Surgery Clinic, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
700    1_
$a Bencko, Vladimir $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic.
700    1_
$a Janout, Vladimir $u Palacky University, Olomouc, Czech Republic.
700    1_
$a Brennan, Paul $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Gaborieau, Valérie $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a McKay, James D $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Boccia, Stefania $u Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, IRCCS Fondazione Policlinico 'Agostino Gemelli', Rome, Italy.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 8, č. 1 (2018), s. 4534
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29540730 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008113445 $b ABA008
999    __
$a ok $b bmc $g 1452012 $s 1073902
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 8 $c 1 $d 4534 $e 20180314 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...